ABT
Price
$134.38
Change
+$0.71 (+0.53%)
Updated
Jun 27 closing price
Capitalization
194.5B
19 days until earnings call
DGX
Price
$177.83
Change
+$0.77 (+0.43%)
Updated
Jun 27 closing price
Capitalization
14.74B
24 days until earnings call
Interact to see
Advertisement

ABT vs DGX

Header iconABT vs DGX Comparison
Open Charts ABT vs DGXBanner chart's image
Abbott Laboratories
Price$134.38
Change+$0.71 (+0.53%)
Volume$9.51M
Capitalization194.5B
Quest Diagnostics
Price$177.83
Change+$0.77 (+0.43%)
Volume$1.21M
Capitalization14.74B
ABT vs DGX Comparison Chart in %
Loading...
ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABT vs. DGX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a StrongBuy and DGX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ABT: $134.38 vs. DGX: $177.83)
Brand notoriety: ABT: Notable vs. DGX: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ABT: 150% vs. DGX: 117%
Market capitalization -- ABT: $194.5B vs. DGX: $14.74B
ABT [@Medical Specialties] is valued at $194.5B. DGX’s [@Medical Specialties] market capitalization is $14.74B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 2 FA rating(s) are green whileDGX’s FA Score has 4 green FA rating(s).

  • ABT’s FA Score: 2 green, 3 red.
  • DGX’s FA Score: 4 green, 1 red.
According to our system of comparison, DGX is a better buy in the long-term than ABT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 3 TA indicator(s) are bullish while DGX’s TA Score has 3 bullish TA indicator(s).

  • ABT’s TA Score: 3 bullish, 4 bearish.
  • DGX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ABT is a better buy in the short-term than DGX.

Price Growth

ABT (@Medical Specialties) experienced а +1.05% price change this week, while DGX (@Medical Specialties) price change was -0.89% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.08%. For the same industry, the average monthly price growth was +1.35%, and the average quarterly price growth was -0.23%.

Reported Earning Dates

ABT is expected to report earnings on Jul 17, 2025.

DGX is expected to report earnings on Jul 22, 2025.

Industries' Descriptions

@Medical Specialties (+1.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABT($194B) has a higher market cap than DGX($14.7B). ABT has higher P/E ratio than DGX: ABT (34.38) vs DGX (17.99). ABT (19.981) and DGX (19.034) have similar YTD gains . ABT has higher annual earnings (EBITDA): 10.5B vs. DGX (1.73B). ABT has more cash in the bank: 7.28B vs. DGX (686M). DGX has less debt than ABT: DGX (5.5B) vs ABT (15.6B). ABT has higher revenues than DGX: ABT (40.1B) vs DGX (9.25B).
ABTDGXABT / DGX
Capitalization194B14.7B1,320%
EBITDA10.5B1.73B606%
Gain YTD19.98119.034105%
P/E Ratio34.3817.99191%
Revenue40.1B9.25B433%
Total Cash7.28B686M1,061%
Total Debt15.6B5.5B284%
FUNDAMENTALS RATINGS
ABT vs DGX: Fundamental Ratings
ABT
DGX
OUTLOOK RATING
1..100
1821
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
10
Undervalued
PROFIT vs RISK RATING
1..100
3729
SMR RATING
1..100
3258
PRICE GROWTH RATING
1..100
3633
P/E GROWTH RATING
1..100
9428
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABT's Valuation (10) in the Medical Specialties industry is in the same range as DGX (10) in the Servicestothe Health Industry industry. This means that ABT’s stock grew similarly to DGX’s over the last 12 months.

DGX's Profit vs Risk Rating (29) in the Servicestothe Health Industry industry is in the same range as ABT (37) in the Medical Specialties industry. This means that DGX’s stock grew similarly to ABT’s over the last 12 months.

ABT's SMR Rating (32) in the Medical Specialties industry is in the same range as DGX (58) in the Servicestothe Health Industry industry. This means that ABT’s stock grew similarly to DGX’s over the last 12 months.

DGX's Price Growth Rating (33) in the Servicestothe Health Industry industry is in the same range as ABT (36) in the Medical Specialties industry. This means that DGX’s stock grew similarly to ABT’s over the last 12 months.

DGX's P/E Growth Rating (28) in the Servicestothe Health Industry industry is significantly better than the same rating for ABT (94) in the Medical Specialties industry. This means that DGX’s stock grew significantly faster than ABT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTDGX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
55%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
58%
Bearish Trend 1 day ago
47%
Momentum
ODDS (%)
Bearish Trend 1 day ago
48%
Bearish Trend 1 day ago
48%
MACD
ODDS (%)
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
52%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
57%
Bearish Trend 1 day ago
44%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
61%
Advances
ODDS (%)
Bullish Trend 6 days ago
59%
Bullish Trend 5 days ago
64%
Declines
ODDS (%)
Bearish Trend 3 days ago
49%
Bearish Trend 3 days ago
46%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
48%
Aroon
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRPH0.380.04
+10.79%
ProPhase Labs
DDD1.520.13
+9.35%
3D Systems Corp
VS2.210.10
+4.74%
Versus Systems
INTA51.120.04
+0.08%
Intapp
PAA18.25-0.02
-0.08%
Plains All American Pipeline LP

ABT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABT has been loosely correlated with MDT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then MDT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
+0.53%
MDT - ABT
51%
Loosely correlated
+0.89%
SYK - ABT
51%
Loosely correlated
+0.81%
ALC - ABT
45%
Loosely correlated
+0.80%
DGX - ABT
44%
Loosely correlated
+0.43%
STE - ABT
43%
Loosely correlated
+0.11%
More

DGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DGX has been closely correlated with LH. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if DGX jumps, then LH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DGX
1D Price
Change %
DGX100%
+0.43%
LH - DGX
67%
Closely correlated
+1.40%
ABT - DGX
44%
Loosely correlated
+0.53%
SYK - DGX
41%
Loosely correlated
+0.81%
TMO - DGX
41%
Loosely correlated
-0.93%
QGEN - DGX
41%
Loosely correlated
-0.56%
More